News
February 12, 2025 R&D
The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center
Pharma Foods International Co., Ltd. (Hereinafter: PFI) and National Cerebral and Cardiovascular Center (Head Office: Suita City, Osaka Prefecture, Chairperson: Kinya Otsu, Heareinafter: NCVC) will jointly establish the world's first "CADASIL Drug Discovery Research Department" with the aim of developing a therapeutic agent for the treatment of CADASIL, a designated intractable disease.
(PDF, 308KB)